Pulmonx
Stand: RD50
Global leader in interventional pulmonology, planning tools and treatments for COPD.
Headquartered in Redwood City, California, and Neuchâtel, Switzerland, Pulmonx is the Zephyr endobronchial valve manufacturer. The Zephyr® endobronchial valve offers bronchoscopic lung volume reduction without the need for surgery and its associated risks.
Address
Suite 4, 7th Floor50 Broadway
London
SW1H 0DB
United Kingdom
Contact Exhibitor
-
The FDA approved the Zephyr® endobrochial valve and granted it breakthrough medical device status in June 2018 because, in its judgment, "it is an innovative technology in offering bronchoscopic lung ...